NASDAQ OMX Copenhagen A/S: Veloxis Pharmaceuticals A/S - reduction of the share capital by reduction of the nominal value per share

Veloxis Pharmaceuticals A/S - reduction of the share capital by reduction of the nominal value per share

The share capital of the following share will be reduced on NASDAQ OMX Copenhagen as per 29 May 2012.

On a general meeting in Veloxis Pharmaceuticals it was adopted to reduce the share capital by reducing the face value per share.

ISIN DK0060048148 -------------------------------------------------------------------------------- Name: Veloxis Pharmaceuticals -------------------------------------------------------------------------------- Volume before 452,542,480 shares each bearing a face value of DKK 1 (DKK change: 452,542,480) -------------------------------------------------------------------------------- Reduction: DKK 407,288,232 -------------------------------------------------------------------------------- Volume after 452,542,480 shares each bearing a face value of DKK 0.1 (DKK change: 45,254,248) -------------------------------------------------------------------------------- New face value: DKK 0.1 -------------------------------------------------------------------------------- Short name: VELO -------------------------------------------------------------------------------- Orderbook ID: 36992 --------------------------------------------------------------------------------

For further information, please contact: Asta Jepsen, Surveillance, tel. [phone]

Attachment:
https://newsclient.omxgroup.com/cds/DisclosureAttachmentServlet?messageAttachmentId=393689